AG
AST.WS

Advisor Group’s Asterias Biotherapeutics Inc. Warrants (expiring September 29, 2017) AST.WS Stock Holding History

Advisor Group’s Portfolio AST.WS Stock Details AST.WS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-97
Closed – – 5153
2017
Q2 		$0 Buy
97
+40
+70% +$18 ﹤0.01% 5099
2017
Q1 		$0 Buy
57
+27
+90% +$10 ﹤0.01% 4983
2016
Q4 		$0 Buy
30
+13
+76% +$7 ﹤0.01% 4847
2016
Q3 		$0 Sell
17
-4
-19% -$1 ﹤0.01% 4853
2016
Q2 		$0 Buy
+21
New +$11 ﹤0.01% 4666

Advisor Group's AST.WS Position: Q3 2017 in Review

Advisor Group sold out of Asterias Biotherapeutics Inc. Warrants (expiring September 29, 2017) (AST.WS) in Q3 2017, closing a stake of 97 shares.

Advisor Group first reported a position in AST.WS in Q2 2016 and held it in 5 quarters. The position peaked at $0 in Q2 2017. 3 funds tracked by Wall St. Rank hold AST.WS as of Q3 2017.

  • Advisor Group reported no remaining Asterias Biotherapeutics Inc. Warrants (expiring September 29, 2017) position as of Q3 2017 after selling out during the quarter.
  • Advisor Group sold 97 Asterias Biotherapeutics Inc. Warrants (expiring September 29, 2017) shares in Q3 2017.
  • Advisor Group first reported a position in Asterias Biotherapeutics Inc. Warrants (expiring September 29, 2017) in Q2 2016 and held it in 5 quarters.
  • Advisor Group's Asterias Biotherapeutics Inc. Warrants (expiring September 29, 2017) position peaked at $0 in Q2 2017.
  • 3 funds tracked by Wall St. Rank held Asterias Biotherapeutics Inc. Warrants (expiring September 29, 2017) as of Q3 2017.

Based on Advisor Group's 13F filing for Q3 2017, filed 6 Nov 2017.